Arcutis Biotherapeutics, Inc. (ARQT)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Todd Franklin Watanabe M.A.
|
President, CEO & Director | 1.31M | -- | 1968 |
|
Dr. Bhaskar Chaudhuri Ph.D.
|
Co-Founder & Director Emeritus | 60.05k | -- | 1955 |
|
Ms. Latha Vairavan
|
Senior VP & Chief Financial Officer | 644.9k | -- | 1978 |
|
Mr. Masaru Matsuda Esq., J.D.
|
Executive VP, Chief Legal Officer & Corporate Secretary | 787.7k | -- | 1971 |
|
Dr. Patrick E. Burnett M.D., Ph.D.
|
Executive VP & Chief Medical Officer | 883.38k | 1.17M | 1972 |
|
Mr. Brian Schoelkopf
|
Head of Investor Relations | -- | -- | -- |
|
Mr. Steve Arias
|
Vice President of Compliance & Privacy | -- | -- | -- |
|
Ms. Amanda Sheldon
|
Head of Corporate Communications | -- | -- | -- |
|
Ms. Aleen Hosdaghian
|
Vice President of Marketing | -- | -- | -- |
|
Mr. Todd Tucker
|
Senior VP & Chief Human Resources Officer | -- | -- | -- |
Arcutis Biotherapeutics, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 354
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Corporate Governance
Upcoming Events
November 4, 2026 at 9:00 PM UTC
Arcutis Biotherapeutics, Inc. Earnings Date
Recent Events
October 10, 2025 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
